David Murray Vernick, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tinnitus | 3 | 2009 | 197 | 0.320 |
Why?
|
| Stapes Surgery | 4 | 1996 | 60 | 0.290 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2023 | 81 | 0.200 |
Why?
|
| Ear, Middle | 3 | 1998 | 341 | 0.190 |
Why?
|
| Labyrinth Diseases | 2 | 2017 | 151 | 0.180 |
Why?
|
| Ear Neoplasms | 4 | 1998 | 118 | 0.160 |
Why?
|
| Deafness | 1 | 2023 | 460 | 0.160 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1998 | 53 | 0.150 |
Why?
|
| Thalassemia | 1 | 1998 | 267 | 0.140 |
Why?
|
| Laser Therapy | 3 | 1996 | 1108 | 0.140 |
Why?
|
| Health Status | 1 | 2009 | 4083 | 0.130 |
Why?
|
| Hearing Loss | 1 | 2023 | 785 | 0.130 |
Why?
|
| Semicircular Canals | 1 | 2017 | 203 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 4053 | 0.120 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 1988 | 782 | 0.090 |
Why?
|
| Vestibular Nerve | 1 | 1990 | 101 | 0.080 |
Why?
|
| Pulse | 1 | 2009 | 217 | 0.080 |
Why?
|
| Earache | 1 | 1987 | 14 | 0.070 |
Why?
|
| Thiazines | 1 | 1986 | 38 | 0.060 |
Why?
|
| Hearing | 2 | 2023 | 504 | 0.060 |
Why?
|
| Skull Neoplasms | 2 | 1998 | 173 | 0.060 |
Why?
|
| Mastoid | 1 | 1984 | 100 | 0.060 |
Why?
|
| Dermoid Cyst | 1 | 1984 | 92 | 0.060 |
Why?
|
| Cochlear Duct | 1 | 1983 | 21 | 0.050 |
Why?
|
| Stria Vascularis | 1 | 1983 | 30 | 0.050 |
Why?
|
| Hyperlipidemias | 1 | 1988 | 770 | 0.050 |
Why?
|
| Hearing Aids | 1 | 2001 | 58 | 0.040 |
Why?
|
| Hearing Loss, Conductive | 1 | 2001 | 159 | 0.040 |
Why?
|
| Neurilemmoma | 1 | 1984 | 522 | 0.040 |
Why?
|
| Paraganglia, Nonchromaffin | 1 | 1998 | 3 | 0.040 |
Why?
|
| Asparagine | 2 | 1976 | 120 | 0.030 |
Why?
|
| Internship and Residency | 2 | 1988 | 5946 | 0.030 |
Why?
|
| von Willebrand Diseases | 1 | 1998 | 135 | 0.030 |
Why?
|
| Cochlea | 1 | 1983 | 848 | 0.030 |
Why?
|
| Speech Reception Threshold Test | 1 | 1996 | 16 | 0.030 |
Why?
|
| Speech Discrimination Tests | 1 | 1996 | 35 | 0.030 |
Why?
|
| Surgical Procedures, Operative | 1 | 1988 | 1931 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1986 | 2271 | 0.030 |
Why?
|
| Meniere Disease | 2 | 1990 | 164 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 1998 | 678 | 0.030 |
Why?
|
| Radiation Genetics | 1 | 1973 | 16 | 0.030 |
Why?
|
| Ear, Inner | 2 | 1990 | 426 | 0.030 |
Why?
|
| Sarcoma, Experimental | 1 | 1973 | 116 | 0.030 |
Why?
|
| Methods | 1 | 1990 | 1061 | 0.020 |
Why?
|
| Humans | 20 | 2023 | 766000 | 0.020 |
Why?
|
| Neck | 2 | 1998 | 734 | 0.020 |
Why?
|
| Cochlear Nerve | 1 | 1990 | 202 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 1973 | 1100 | 0.020 |
Why?
|
| Anesthesia, Inhalation | 1 | 1988 | 220 | 0.020 |
Why?
|
| Otitis Media with Effusion | 1 | 1988 | 115 | 0.020 |
Why?
|
| Piroxicam | 1 | 1986 | 18 | 0.020 |
Why?
|
| Ear | 1 | 1987 | 172 | 0.020 |
Why?
|
| Temporal Bone | 2 | 1998 | 683 | 0.020 |
Why?
|
| Auditory Threshold | 1 | 1988 | 369 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2017 | 2078 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1990 | 1138 | 0.020 |
Why?
|
| Safety | 1 | 1990 | 1157 | 0.020 |
Why?
|
| Electronystagmography | 1 | 1984 | 25 | 0.010 |
Why?
|
| Cholesteatoma | 1 | 1984 | 28 | 0.010 |
Why?
|
| Audiometry, Evoked Response | 1 | 1984 | 45 | 0.010 |
Why?
|
| Otitis Media | 1 | 1987 | 287 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1998 | 2926 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1986 | 1607 | 0.010 |
Why?
|
| Endolymph | 1 | 1983 | 20 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1990 | 1440 | 0.010 |
Why?
|
| Adult | 6 | 2023 | 223106 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1998 | 12975 | 0.010 |
Why?
|
| Middle Aged | 7 | 2001 | 223025 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1998 | 8925 | 0.010 |
Why?
|
| Male | 10 | 2001 | 363855 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 13463 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1998 | 36545 | 0.010 |
Why?
|
| Head | 1 | 1987 | 926 | 0.010 |
Why?
|
| Bone Conduction | 1 | 2001 | 102 | 0.010 |
Why?
|
| Arthritis | 1 | 1986 | 676 | 0.010 |
Why?
|
| Child | 3 | 2023 | 80567 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1998 | 20698 | 0.010 |
Why?
|
| Petrous Bone | 1 | 1998 | 85 | 0.010 |
Why?
|
| Atrophy | 1 | 1983 | 1627 | 0.010 |
Why?
|
| Tongue Neoplasms | 1 | 1998 | 185 | 0.010 |
Why?
|
| Nitrosoguanidines | 1 | 1976 | 8 | 0.010 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 1976 | 18 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2001 | 1253 | 0.010 |
Why?
|
| Quinacrine | 1 | 1976 | 24 | 0.010 |
Why?
|
| Female | 9 | 2001 | 396158 | 0.010 |
Why?
|
| Nose Neoplasms | 1 | 1998 | 249 | 0.010 |
Why?
|
| Ethyl Methanesulfonate | 1 | 1976 | 29 | 0.010 |
Why?
|
| Mesylates | 1 | 1976 | 37 | 0.010 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 1998 | 287 | 0.010 |
Why?
|
| Skull Base Neoplasms | 1 | 1998 | 276 | 0.010 |
Why?
|
| Azaguanine | 1 | 1974 | 2 | 0.010 |
Why?
|
| Neuroma, Acoustic | 1 | 1998 | 456 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2001 | 1475 | 0.010 |
Why?
|
| Wounds and Injuries | 1 | 1987 | 2513 | 0.010 |
Why?
|
| Radiography | 1 | 1984 | 6943 | 0.010 |
Why?
|
| Massachusetts | 1 | 1986 | 8882 | 0.010 |
Why?
|
| Equipment Design | 1 | 2001 | 3488 | 0.010 |
Why?
|
| Aged | 3 | 2001 | 171161 | 0.010 |
Why?
|
| Genes | 1 | 1976 | 1824 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2001 | 2249 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 1973 | 870 | 0.010 |
Why?
|
| Clinical Competence | 1 | 1986 | 4859 | 0.010 |
Why?
|
| Mutation | 3 | 1976 | 30208 | 0.010 |
Why?
|
| Child, Preschool | 3 | 1988 | 42509 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 1996 | 65199 | 0.000 |
Why?
|
| Drug Resistance | 1 | 1974 | 1592 | 0.000 |
Why?
|
| Acoustic Impedance Tests | 1 | 1988 | 111 | 0.000 |
Why?
|
| Sarcoma | 1 | 1998 | 1801 | 0.000 |
Why?
|
| Cell Survival | 2 | 1976 | 5744 | 0.000 |
Why?
|
| Middle Ear Ventilation | 1 | 1988 | 101 | 0.000 |
Why?
|
| Infant | 2 | 1988 | 36424 | 0.000 |
Why?
|
| Cell Division | 1 | 1973 | 4467 | 0.000 |
Why?
|
| Cell Line | 2 | 1976 | 15545 | 0.000 |
Why?
|
| Posture | 1 | 1988 | 955 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1998 | 4047 | 0.000 |
Why?
|
| Ear Diseases | 1 | 1984 | 181 | 0.000 |
Why?
|
| Otolaryngology | 1 | 1988 | 698 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1998 | 9378 | 0.000 |
Why?
|
| Adolescent | 1 | 1986 | 88808 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1973 | 18964 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2001 | 59493 | 0.000 |
Why?
|
| Aminopterin | 1 | 1974 | 15 | 0.000 |
Why?
|
| Hypoxanthines | 1 | 1974 | 35 | 0.000 |
Why?
|
| Pentosyltransferases | 1 | 1974 | 62 | 0.000 |
Why?
|
| Thymidine | 1 | 1974 | 294 | 0.000 |
Why?
|
| Culture Media | 1 | 1974 | 889 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2001 | 81542 | 0.000 |
Why?
|
| Clone Cells | 1 | 1974 | 1670 | 0.000 |
Why?
|
| Cricetinae | 1 | 1974 | 2413 | 0.000 |
Why?
|
| Rats | 1 | 1987 | 23709 | 0.000 |
Why?
|
| Animals | 3 | 1987 | 168775 | 0.000 |
Why?
|
| Ovary | 1 | 1974 | 961 | 0.000 |
Why?
|
| Probability | 1 | 1974 | 2475 | 0.000 |
Why?
|
| Phenotype | 2 | 1976 | 16712 | 0.000 |
Why?
|